Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ibodutant
DRUG
2 trials
Sponsors
Menarini Group
Conditions
Irritable Bowel Syndrome
Irritable Bowel Syndrome With Diarrhea
Phase 2
Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)
Completed
NCT00761007
Menarini Group
Irritable Bowel Syndrome
Start: 2008-07-31
End: 2009-03-31
Updated: 2012-03-21
Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)
Completed
NCT01303224
Menarini Group
Irritable Bowel Syndrome With Diarrhea
Start: 2010-10-31
End: 2012-07-31
Updated: 2015-10-07
Related Papers
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
Gut
2016-04-15
52 citations